Citations

Mayo Clinic

Showing 10 of 108602 citations.

Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide
Harrison, Claire , Mead, Adam J. , Panchal, Anesh, Fox, Sonia, Yap, Christina , Gbandi, Emmanouela, Houlton, Aimee E., Alimam, Samah , Ewing, Joanne, Wood, Marion , Chen, Frederick , Coppell, Jason, Panoskaltsis, Nicki , Knapper, Steven , Ali, Sahra, Hamblin, Angela , Scherber, Robyn M. , Dueck, Amylou C. , Jackson, Aimee , Scherber, Robyn, Mesa, Ruben, Dueck, A. C. , Mead, Adam J , Cross, Nicholas C.P. , Mesa, Ruben A. , McMullin, Mary Frances , Knapper, Steven , Yap, Christina

Blood | August 9, 2017 | Volume: 130 | Issue: 17 | Pages: 1889-1897

10.1182/blood-2017-05-785790 | PMID 29074595 Get It

Key Points After hydroxycarbamide therapy in high-risk ET, ruxolitinib showed no improvement for complete or partial response rates compared with BAT. Ruxolitinib significantly improved some disease-related symptoms, but rates of thrombosis, hemorrhage, or transformation were not different.
Physiology in Perspective: The Value of Integrative Physiology
Sieck, Gary C. , Sieck, Gary

Physiology | August 9, 2017 | Volume: 32 | Issue: 5 | Pages: 344-345

10.1152/physiol.00018.2017 | PMID 28794214 Get It

Current Concepts in the Treatment of Renovascular Hypertension
Herrmann, Sandra M. , Textor, Stephen C., Herrmann, Sandra M

American Journal of Hypertension | August 9, 2017 | Volume: 31 | Issue: 2 | Pages: 139-149

10.1093/ajh/hpx154 | PMID 28985335 Get It

AbstractRenovascular disease (RVD) remains a major cause of secondary and treatment-resistant hypertension. Most cases are related either to fibromuscular or atherosclerotic lesions, but a variety of other causes including arterial dissection, stent occlusion, and embolic disease can produce the same syndrome. Recent studies emphasize the kidney’s tolerance to moderate flow reduction during antihypertensive drug therapy and the relative safety of medical therapy to control blood pressure. Several prospective trials in moderate RVD fail to identify major benefits from endovascular revascularization for moderate atherosclerotic disease. However, high-risk and progressive renovascular syndromes are recognized to be relatively refractory to medical therapy only and respond better to combining renal revascularization with ongoing medical therapy. Clinicians caring for complex hypertension should be familiar with pathogenic pathways, imaging techniques, and a rational approach to managing renovascular hypertension in the current era.
The effect of full dose composite tissue allotransplantation immunosuppression on allograft motor nerve regeneration in a rat sciatic nerve model
Kim, Jong Pil , Hundepool, Caroline A. , Friedrich, Patricia F. , Moran, Steven L. , Bishop, Allen T. , Shin, Alexander Y.

Microsurgery | August 9, 2017 | Volume: 38 | Issue: 1 | Pages: 66-75

10.1002/micr.30211 | PMID 28792625 Get It

BackgroundThe purpose of this study was to identify which triple immunosuppressive protocols, currently used for vascularized composite allotransplantation in the clinic, will have the best effect on motor function recovery following nerve allograft reconstruction.MethodsEighty‐eight Lewis rats underwent a 1‐cm sciatic nerve allograft transplantation and skin graft from 44 Brown‐Norway rats. Group I received 0.9% isotonic saline (control); Group II, 2 mg/kg FK506; Group III, 1 mg/kg FK506 with 15 mg/kg mycophenolate mofetil (MMF); and Group IV, 2 mg/kg FK506 with 30 mg/kg MMF and prednisone. Each group consisted of 11 rats. After 12 weeks, motor function recovery was evaluated with isometric tetanic force, muscle mass, ankle contracture angle, electrophysiology, and nerve histomorphometry. Adequacy of immunosuppression was monitored with the transplanted skin graft. All data are expressed as a percentage of the contralateral side.ResultsIsometric tetanic force showed significantly better functional recovery in all groups treated with immunosuppression compared to control. Within the immunosuppression groups no significant difference was found: 42.1 ± 6.4% (Group I), 56.1 ± 12.4% (Group II), 58.4 ± 10.7% (Group III), and 61.3 ± 11.2% (Group IV). Group IV was superior to all other groups regarding ankle contracture (P < .05) and electrophysiology (P < .001). Skin graft rejection occurred in 41 and 0% (Groups III and IV, respectively).ConclusionsFK506 significantly enhanced motor recovery after allograft reconstruction. This effect was comparable between combination treatment (low‐dose FK506 and MMF) and triple therapy (high‐dose FK506 and MMF plus prednisolone). However, triple therapy was more effective in suppressing skin rejection.
The importance of normal pressures in the compartment of the leg
Grewal, Sanjeet S. , Amrami, Kimberly K. , Murthy, Naveen S. , Spinner, Robert J. , Grewal, Sanjeet

Clinical Anatomy | August 9, 2017 | Volume: 30 | Issue: 8 | Pages: 1002-1004

10.1002/ca.22975 | PMID 28791732 Get It

Perspectives, Decision Making, and Final Mode of Delivery in Pregnant Women With a Previous C-Section in a General Hospital in Peru: Prospective Analysis
Lazo-Porras, María , Bayer, Angela M. , Zeballos‐Palacios, Claudia , Cárdenas-Montero, Deborah, Reyes-Díaz, Michael , Naranjo-Caceres, Monica, Acuña-Villaorduña, Ana, Zeballos-Palacios, Claudia, Acuña-Villaorduña, Ana , Málaga, Germán

MDM Policy & Practice | August 9, 2017 | Volume: 2 | Issue: 2 | Pages: No page available

10.1177/2381468317724409 | PMID 30288428 Get It

Objective: Explore the perspectives, decision-making process, and final mode of delivery among pregnant women with a previous C-section (Cesarean section) in a general public sector hospital in Lima, Peru. Methods: A qualitative prospective study using semistructured interviews at two time points in the outpatient obstetrics and gynecology clinic of a public sector, university-affiliated reference hospital in Lima, Peru. Seventeen adult pregnant women with a prior C-section who were deemed by their attending obstetrician to be candidates for a trial of labor were interviewed. The first interview was between 37 and 38 weeks of pregnancy, and the second interview was 24 to 48 hours after delivery. Main outcome measures: Predelivery decision-making process and final mode of delivery. Results: Among the 17 participants, about half (9) of the participants stated that the physician explained that they had two approaches for delivery, a trial of labor after C-section (TOLAC) or elective repeated C-section (ERCD). Two women stated that their respective providers explained only one option, either an ERCD or TOLAC. However, 6 women did not receive any information from their providers about their delivery options. Of the 10 participants that decided TOLAC, 8 ended up having a C-section, and of the 7 patients that had planned an ERCD, 1 ended up having a vaginal delivery. Conclusion: Many participants affirmed that they made the decision about their approach of delivery. However, most of the participants that decided a TOLAC ended up having a C-section because of complications during the final weeks of pregnancy or during labor.
Letter by Zakeri and Redfield Regarding Article, “Influence of Left Atrial Function on Exercise Capacity and Left Ventricular Function in Patients With Heart Failure and Preserved Ejection Fraction”
Zakeri, Rosita , Redfield, Margaret M. , Zakeri, Rosita

Circulation: Cardiovascular Imaging | August 9, 2017 | Volume: 10 | Issue: 8 | Pages: No page available

10.1161/circimaging.117.006705 | PMID 28790124 Get It

Association Between Echocardiography Laboratory Accreditation and the Quality of Imaging and Reporting for Valvular Heart Disease
Thaden, Jeremy J. , Tsang, Michael , Padang, Ratnasari , Tucker, Stephen F., Cassidy, Cynthia S., Bremer, Merri L., Kane, Garvan C. , Pellikka, Patricia A. , Tsang, Michael Y, Bremer, Merri, Pellikka, Patricia A , Nkomo, Vuyisile T.

Circulation: Cardiovascular Imaging | August 9, 2017 | Volume: 10 | Issue: 8 | Pages: No page available

10.1161/circimaging.117.006140 | PMID 28790122 Get It

Background— It is presumed that echocardiographic laboratory accreditation leads to improved quality, but there are few data. We sought to compare the quality of echocardiographic examinations performed at accredited versus nonaccredited laboratories for the evaluation of valvular heart disease. Methods and Results— We enrolled 335 consecutive valvular heart disease subjects who underwent echocardiography at our institution and an external accredited or nonaccredited institution within 6 months. Completeness and quality of echocardiographic reports and images were assessed by investigators blinded to the external laboratory accreditation status and echocardiographic results. Compared with nonaccredited laboratories, accredited sites more frequently reported patient sex (94% versus 78%; P <0.001), height and weight (96% versus 63%; P <0.001), blood pressure (86% versus 39%; P <0.001), left ventricular size (96% versus 83%; P <0.001), right ventricular size (94% versus 80%; P =0.001), and right ventricular function (87% versus 73%; P =0.006). Accredited laboratories had higher rates of complete and diagnostic color (58% versus 35%; P =0.002) and spectral Doppler imaging (45% versus 21%; P <0.0001). Concordance between external and internal grading of external studies was improved when diagnostic quantification was performed (85% versus 69%; P =0.003), and in patients with mitral regurgitation, reproducibility was improved with higher quality color Doppler imaging. Conclusions— Accredited echocardiographic laboratories had more complete reporting and better image quality, while echocardiographic quantification and color Doppler image quality were associated with improved concordance in grading valvular heart disease. Future quality improvement initiatives should highlight the importance of high-quality color Doppler imaging and echocardiographic quantification to improve the accuracy, reproducibility, and quality of echocardiographic studies for valvular heart disease.
Editorial Comment
Colicchia, Michele , Karnes, R. Jeffrey

Journal of Urology | August 8, 2017 | Volume: 198 | Issue: 5 | Pages: 1084-1084

10.1016/j.juro.2017.06.101 | PMID 28801257 Get It

Comparative Cost Analysis of Endoscopic versus Microscopic Endonasal Transsphenoidal Surgery for Pituitary Adenomas
Eseonu, Chikezie I. , ReFaey, Karim , García, Óscar , Salvatori, Roberto , Quiñones‐Hinojosa, Alfredo , ReFaey, Karim

Journal of Neurological Surgery Part B: Skull Base | August 8, 2017 | Volume: 79 | Issue: 02 | Pages: 131-138

10.1055/s-0037-1604484 | PMID 29868317 Get It

Objective This study presents a comparative analysis of cost efficacy between the microscopic and endoscopic transsphenoidal approaches, evaluating neurological outcome, extent of resection (EOR), and inpatient hospital costs. Design This study was a retrospective chart review. Setting This study was conducted at a tertiary care center. Participants The study group consisted of 68 patients with transsphenoidal surgeries between January 2007 and January 2014. Main Outcome Measures Two-sample t-tests and Pearson's chi-square test evaluated inpatient costs, quality-adjusted life years (QALYs), volumetric EOR, and neurological outcomes. Results Total inpatient costs per patient was $22,853 in the microscopic group and less ($19,736) in the endoscopic group (p = 0.049). Operating room costs were $5,974 in the microscopic group and lower in the endoscopic group ($5,045; p = 0.038). Operative time was 203.6 minutes in the microscopic group and 166.3 minutes in the endoscopic group (p = 0.032). The QALY score, length of hospital stay, and postoperative outcomes were found to be similar between the two cohorts. Multivariate linear regression modeling suggested that length of stay (p < 0.001) and operative time (p = 0.008) were important factors that influenced total inpatient costs following transsphenoidal surgery. Conclusion This study shows that transsphenoidal surgery is more cost effective with the endoscopic approach than with the microscopic approach and depends on efficiency in the operating room as well as reduction in the length of hospitalization.